PRESS RELEASE
News
-
-
-
PRESS RELEASE
Fresenius completes acquisition of mAbxience, creating a stronger platform for future portfolio expansion
Fresenius completes acquisition of mAbxience, enhancing biosimilars platform to support future innovation and patient access. Full ownership strengthens quality and supply resilience -
-
PRESS RELEASE
Press Release: Sanofi and Regeneron expand global Alliance with multiple next-generation, long-acting immunology antibodies
Sanofi and Regeneron expand global Alliance with long-acting immunology antibodies, including REGN20423, IL-13 antibody. $1 billion upfront payment and potential $7 billion milestone payments announced -
PRESS RELEASE
Emerald Clinical Trials Appoints Michael Stibilj as Chief Executive Officer to Lead Next Phase of Global Growth
Emerald Clinical Trials appoints Michael Stibilj as Chief Executive Officer to lead global growth phase. Stibilj brings 30 years of industry experience, focusing on Asia-Pacific market expansion -
-
PRESS RELEASE
Algo Grande Copper Secures Five-Year Surface Access Agreement With Ejido Palos Chinos at the Adelita Project
Algo Grande Copper Corp. secures surface access for Adelita Project in Mexico with a five-year Agreement with Ejido Palos Chinos. CEO emphasizes respect and transparency in the relationship. Company focuses on sustainability and community engagement -
-
PRESS RELEASE
Half yearly financial reports and audit reports/limited reviews / Terms of availability of the half-yearly financial report
ABL Texcell Diagnostics (Euronext Paris: ABLD) releases 2026 Half-Year Financial Report. Statutory auditor's report confirms accuracy. Products include PCR tests and genotyping services
